Repositorio de producción científica de la Universidad de Sevilla

In vitro Activity of Pentamidine Alone and in Combination With Aminoglycosides, Tigecycline, Rifampicin, and Doripenem Against Clinical Strains of Carbapenemase-Producing and/or Colistin-Resistant Enterobacteriaceae

 

Advanced Search
 
Opened Access In vitro Activity of Pentamidine Alone and in Combination With Aminoglycosides, Tigecycline, Rifampicin, and Doripenem Against Clinical Strains of Carbapenemase-Producing and/or Colistin-Resistant Enterobacteriaceae
Cites

Show item statistics
Icon
Export to
Author: Cebrero Cangueiro, Tania
Álvarez Marín, Rocío
Labrador Herrera, Gema
Smani, Younes
Cordero Matía, María Elisa
Department: Instituto de Biomedicina de Sevilla (IBIS)
Date: 2018-10-18
Published in: Frontiers in cellular and infection microbiology, 8, 363-1-363-7.
Document type: Article
Abstract: Enterobacteriaceae cause different types of community- and hospital-acquired infections. Moreover, the spread of multidrug-resistant Enterobacteriaceae is a public health problem and the World Health Organization pointed them among the pathogens in ...
[See more]
Cite: Cebrero Cangueiro, T., Álvarez Marín, R., Labrador Herrera, G., Smani, Y. y Cordero Matía, M.E. (2018). In vitro Activity of Pentamidine Alone and in Combination With Aminoglycosides, Tigecycline, Rifampicin, and Doripenem Against Clinical Strains of Carbapenemase-Producing and/or Colistin-Resistant Enterobacteriaceae. Frontiers in cellular and infection microbiology, 8, 363-1-363-7.
Size: 3.523Mb
Format: PDF

URI: https://hdl.handle.net/11441/81612

DOI: 10.3389/fcimb.2018.00363

See editor´s version

This work is under a Creative Commons License: 
Attribution-NonCommercial-NoDerivatives 4.0 InternacionalAttribution-NonCommercial-NoDerivatives 4.0 Internacional

This item appears in the following Collection(s)